Therapeutic Strategy for Efficient Reduction of Serum Uric Acid Levels with Allopurinol versus Benzbromarone in Hyperuricemic Patients with Essential Hypertension-A Randomized Crossover Study (TERAO study)
Not Applicable
- Conditions
- hyperuricemia
- Registration Number
- JPRN-UMIN000023905
- Lead Sponsor
- Division of Cardiovascular Medicine, Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 14
Inclusion Criteria
Not provided
Exclusion Criteria
patients in whom informed consent could not be received.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the change of serum and urine urate and proteinuria
- Secondary Outcome Measures
Name Time Method